Expanded Access for LJPC-501

Summary

The primary objective of the study is to provide access to LJPC-501 for distributive shock patients who remain hypotensive despite receiving fluid and vasopressor therapy.

Timeline

Start

—

Primary completion

—

Completion

—

Drugs

Indications